Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally
Clinical trial NCT02957929 · COMPLETED
Trial details
- NCT number
- NCT02957929
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-31
- Primary completion
- 2017-04-20
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.